Skip to main content

Hypopituitary Dwarfism

  • Chapter
  • 230 Accesses

Part of the book series: Clinical Surveys in Endocrinology ((CSED,volume 1))

Abstract

The pediatric definition of the term dwarfism is applied to children whose height is 4 standard deviations or more (≥4 SD) below the mean of their coevals. Primary disturbances in growth regulation can be caused by a myriad of disease states. Intrinsic abnormalities of bone or cartilage as well as numerous systemic diseases affect growth (Table 26). The focus in this chapter

Table 26 Causes of Short Stature

is on growth retardation caused by hyposomatotropism. Several terms used in the past, including primordial dwarfism, ateleotic dwarfism, genetic dwarfism, and constitutional dwarfism, have been mostly discarded currently, owing to the meaningless nature of such terms. It used to be believed that growth hormone (GH) deficiency represented a relatively uncommon (5–10%) cause of growth retardation. This belief was fostered in an era when GH deficiency was a relatively simple and straightforward entity (i.e., failure to grow was clearly a result of failure to generate GH by the anterior pituitary). In the short span of merely the past 10 years, GH-related growth disorders have come to be recognized as a heterogeneous group of disorders with diverse underlying mechanisms. Indeed, this entity is rapidly being elevated to the status of a fairly common etiology for growth retardation. Regardless of the frequency of occurrence, GH-related growth disorder may be the only group— besides hypothyroidism—in which some therapeutic rewards are attainable; a fact that is especially important, since delays in diagnosis can cost tremendous psychosocial maladjustments.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wehrenberg WB, Brazeau P, Luben R, et al: Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to hypothalamic growth hormone releasing factor. Endocrinology 111:2147, 1982.

    Article  PubMed  CAS  Google Scholar 

  2. Phillips LS, Vassilopoulou-Sellin R: Somatomedins. N Engl J Med 302:371, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Talwar GP, Pandian MR, Kumar N, et al: Mechanism of action of pituitary growth hormone. Recent Prog Horm Res 31:141, 1975.

    PubMed  CAS  Google Scholar 

  4. Phillips LS, Fusco AC, Unterman TG: Nutrition and somatomedin. XIV. Altered levels of somatomedins and somatomedin inhibitors in rats with streptozotocin-induced diabetes. Metabolism 34:765, 1985.

    Article  PubMed  CAS  Google Scholar 

  5. Phillips LS, Orawski AT, Belosky DC: Somatomedin and nutrition. IV. Regulation of somatomedin activity and growth cartilage activity by quantity and composition of diet in rats. Endocrinology 103:121, 1978.

    Article  PubMed  CAS  Google Scholar 

  6. Phillips LS, Orawski AT: Nutrition and somatomedin. III. Diabetic control, somatomedin, and growth in rats. Diabetes 26:864, 1977.

    PubMed  CAS  Google Scholar 

  7. Pugliese MT, Lifshitz F, Grad G, et al: Fear of obesity: A cause of short stature and delayed puberty. N Engl J Med 309:513, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Lucas AR: Undernutrition and growth. (Editorial.) N Engl J Med 309:550, 1983.

    Article  PubMed  CAS  Google Scholar 

  9. Laron Z, Keret R, Bauman B, et al: Differential diagnosis between hypothalamic and pituitary hGH deficiency with the aid of synthetic GH-RH 1-44.Clin Endocrinol (Oxf) 21:9, 1984.

    Article  CAS  Google Scholar 

  10. Yalow RS, Hall K, Luft R: Radioimmunoassay of somatomedin B: Application to clinical and physiologic studies. J Clin Invest 55:127, 1975.

    Article  PubMed  CAS  Google Scholar 

  11. Schalch DS, Heinrich UE, Koch JG, et al: Non-suppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels. J Clin Endocrinol Metabl 46:664, 1978.

    Article  CAS  Google Scholar 

  12. Furlanetto RW, Underwood LE, Van Wyk JJ, et al: Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648, 1977.

    Article  PubMed  CAS  Google Scholar 

  13. Miller WL, Eberhardt NL, Baxter JD: Growth hormone genes. In Black PM, Zervas NT, Ridgeway EC, et al (eds): Secretory Tumors of the Pituitary Gland. Progress in Endocrine Research and Therapy. Vol. 1. Raven, New York, 1984, p. 135.

    Google Scholar 

  14. Guillemin R, Brazeau P, Böhlen P, et al: Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218:585, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Rivier J, Spiess J, Thorner M, et al: Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (Lond) 300:276, 1982.

    Article  CAS  Google Scholar 

  16. Thorner MO, Rivier J, Spiess J, et al: Human pancreatic growth-hormone releasing factor selectively stimulates growth-hormone secretion in man. Lancet 1:24, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Gelato MC, Pescovits O, Cassorla F, et al: Effects of a growth hormone releasing factor in man. J Clin Endocrinol Metab 57:674, 1983.

    Article  PubMed  CAS  Google Scholar 

  18. Rosenthal SM, Schriock EA, Kaplan SL, et al: Synthetic human pancreatic growth hormone-releasing factor stimulates growth hormone secretion in normal man. J Clin Endocrinol Metab 57:677, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. Borges JLC, Blizzard RM, Gelato MC, et al: Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin-C levels in patients with idiopathic growth hormone deficiency. Lancet 2:119, 1983.

    Article  PubMed  CAS  Google Scholar 

  20. Grossman A, Savage MO, Wass JAH: Growth-hormone-releasing factor in growth hormone deficiency: Demonstration of a hypothalamic defect in growth hormone release. Lancet 2:137, 1983.

    Article  PubMed  CAS  Google Scholar 

  21. Borges JLC, Blizzard RM, Evans WS, et al: Stimulation of growth hormone (GH) and somatomedin-C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor. J Clin Endocrinol Metab 59:1, 1984.

    Article  PubMed  CAS  Google Scholar 

  22. Schechter J, Kovacs K, Rimoin D: Isolated growth hormone deficiency: Immunocytochemistry. J Clin Endocrinol Metab 59:798, 1984.

    Article  PubMed  CAS  Google Scholar 

  23. Rogol AD, Blizzard RM, Johanson AJ, et al: Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 children with short stature. J Clin Endocrinol Metab 59:580, 1984.

    Article  PubMed  CAS  Google Scholar 

  24. Gelato MC, Ross JL, Malozowski S, et al: Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. J Clin Endocrinol Metab 61:444, 1985.

    Article  PubMed  CAS  Google Scholar 

  25. Thorner MO, Reschke J, Chitwood J, et al: Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 312:4, 1985.

    Article  PubMed  CAS  Google Scholar 

  26. Phillips JA III: Genetic diagnosis: Differentiating growth disorders. Hosp Pract 20:85, 1985.

    Google Scholar 

  27. Phillips JA III, Hjelle BL, Seeberg PH, et al: A molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci USA 78:6372, 1981.

    Article  PubMed  CAS  Google Scholar 

  28. Phillips JA III: The molecular basis of familial growth hormone deficiency. In Messer A, Porter IH (eds): Recombinant DNA and Medical Genetics. Academic, New York, 1983, p. 9.

    Google Scholar 

  29. Phillips JA III, Parks JS, Hjelle BL, et al: Genetic analysis of familial isolated growth hormone deficiency Type I. J Clin Invest 70:489, 1982.

    Article  PubMed  Google Scholar 

  30. Spiliotis BE, August GP, Hung W, et al: Growth hormone neurosecretory dysfunction: A treatable cause of short stature. JAMA 251:2223, 1984.

    Article  PubMed  CAS  Google Scholar 

  31. Kowarski AA, Schneider J, Ben-Galim E, et al: Growth failure with normal serum RIA-GH and low somatomedin activity: Somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab 47:461, 1978.

    Article  PubMed  CAS  Google Scholar 

  32. Hayek A, Peake GT: Growth and somatomedin-C responses to growth hormone in dwarfed children. J Pediatr 99:868, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Frazer T, Gavin JR, Daughaday WH, et al: Growth hormone-dependent growth failure. J Pediatr 101:12, 1982.

    Article  PubMed  CAS  Google Scholar 

  34. Rudman D, Kutner MH, Blackston RD, et al: Normal variant short stature: Subclassification based on responses to exogenous human growth hormone. J Clin Endocrinol Metab 49:92, 1979.

    Article  PubMed  CAS  Google Scholar 

  35. Rudman D, Kutner MH, Goldsmith MA, et al: Further observations on four subgroups of normal variant short stature. J Clin Endocrinol Metab 51:1378, 1980.

    Article  PubMed  CAS  Google Scholar 

  36. Rudman D, Kutner MH, Blackston RD, et al: Children with normal-variant short stature: Treatment with human growth hormone for six months. N Engl J Med 305:123, 1981.

    Article  PubMed  CAS  Google Scholar 

  37. Preece, MA: A new task for human growth hormone? Br Med J 283:1145, 1981.

    Article  CAS  Google Scholar 

  38. Van Vliet G, Styne DM, Kaplan SL, et al: Growth hormone treatment for short stature. N Engl J Med 309:1016, 1983.

    Article  PubMed  Google Scholar 

  39. Friesen HG: Raben lecture: a tale of stature. Endocr Rev 1:309, 1980.

    Article  PubMed  CAS  Google Scholar 

  40. Valenta LJ, Sigel MB, Lesniak MA, et al: Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl] Med 312:214, 1985.

    Article  CAS  Google Scholar 

  41. Gorden P, Hendricks CM, Roth J: Evidence for “big” and “little” components of human plasma and pituitary growth hormone. J Clin Endocrinol Metab 36:178, 1973.

    Article  PubMed  CAS  Google Scholar 

  42. Abucham-Filho JZ, Czepielewski MA, Ribeiro SRR, et al: Abnormal growth hormone and dwarfism. TV Engl J Med 313:268, 1985.

    CAS  Google Scholar 

  43. Laron Z, Pertzelan A, Mannheimer S: Genetic pituitary dwarfism with high serum concentration of growth hormone-A new inborn error of metabolism? Israel] Med Sci 2:152, 1966.

    CAS  Google Scholar 

  44. Laron Z, Pertzelan A, Karp M: Pituitary dwarfism with high serum levels of growth hormone. Israel J Med Sci 4:883, 1968.

    PubMed  CAS  Google Scholar 

  45. Laron Z, Pertzelan A, Karp M, et al: Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: Measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol 33:332, 1971.

    Article  CAS  Google Scholar 

  46. Laron Z, Kowadlo-Silbergeld A, Eshet R, et al: Growth hormone resistance. Ann Clin Res 12:269, 1980.

    PubMed  CAS  Google Scholar 

  47. Merimee TJ, Rimoin DL, Rabinowitz D, et al: Metabolic studies in the African pygmy. Trans Assoc Am Physicians 81:221, 1968.

    PubMed  CAS  Google Scholar 

  48. Merimee TJ, Rimoin DL, Cavalli-Sforza LL: Metabolic studies in the African pygmy. J Clin Invest 51:395, 1972.

    Article  PubMed  CAS  Google Scholar 

  49. Rimoin DL, Merimee TJ, McKusick VA: Growth-hormone deficiency in man: An isolated, recessively inherited defect. Science 152:1635, 1966.

    Article  PubMed  CAS  Google Scholar 

  50. Merimee TJ, Zapf J, Froesch ER: Dwarfism in the pygmy: An isolated deficiency of insulinlike growth Factor I. N Engl J Med 305:965, 1981.

    Article  PubMed  CAS  Google Scholar 

  51. Rosenfeld RG, Hintz RL: Diagnosis and management of growth disorders. Drug Therapy 13:61, 1983.

    Google Scholar 

  52. Rosenfeld RG: Evaluation of growth and maturation in adolescence. Pediatr Rev 4:175, 1982.

    Article  Google Scholar 

  53. Post EM, Richman RA: A condensed table for predicting adult stature. J Pediatr 98:440, 1981.

    Article  PubMed  CAS  Google Scholar 

  54. Blethen SL, Chasalow FI: Use of a two-site immunoradiometric assay for growth hormone (GH) in identifying children with GH-dependent growth failure. J Clin Endocrinol Metabl 57:1031, 1983.

    Article  CAS  Google Scholar 

  55. Frisch H, Herkner K, Schober E, et al: Prolactin and thyrotrophin response to thyrotrophin-releasing hormone in growth hormone deficiency. Arch Dis Child 57:769, 1982.

    Article  PubMed  CAS  Google Scholar 

  56. Bucher H, Zapf J, Torresani T, et al: Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 309:1142, 1983.

    Article  PubMed  CAS  Google Scholar 

  57. Powell GF, Brasel J A, Blizzard RM: Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. N Engl J Med 276:1271, 1967.

    Article  PubMed  CAS  Google Scholar 

  58. Powell GF, Brasel JA, Raid S, et al: Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. II. Endocrinologic evaluation of the syndrome. N Engl J Med 276:1279, 1967.

    Article  PubMed  CAS  Google Scholar 

  59. Raben MS: Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18:901, 1958.

    Article  PubMed  CAS  Google Scholar 

  60. Tanner JM, Whitehouse RH, Hughes PCR, et al: Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner’s syndrome and other complaints. Arch Dis Child 46:745, 1971.

    Article  PubMed  CAS  Google Scholar 

  61. Preece MA, Tanner JM, Whitehouse RH, et al: Dose dependence of growth response to human growth hormone in growth hormone deficiency. J Clin Endocrinol Metab 42:477, 1976.

    Article  PubMed  CAS  Google Scholar 

  62. Milner RDG, Russell-Fraser T, Brook CGD, et al: Experience with human growth hormone in Great Britain: The report of the MRC working party. Clin Endocrinol 11:15, 1979.

    Article  CAS  Google Scholar 

  63. Aceto T, Frasier SD, Hayles AB, et al: Collaborative study of the effects of human growth hormone in growth hormone deficiency. I. First year of therapy. J Clin Endocrinol Metab 35:483, 1972.

    Article  PubMed  Google Scholar 

  64. Frasier SD: Human pituitary growth hormone(hGH) therapy in growth hormone deficiency. Endocr Rev 4:155, 1983.

    Article  PubMed  CAS  Google Scholar 

  65. Seip M, Trygstad O: Experiences with human growth hormone in pituitary dwarfism. Acta Paediatr Scand 55:287, 1966.

    Article  PubMed  CAS  Google Scholar 

  66. Frasier SD, Aceto T, Hayles AB: Collaborative study of the effects of human growth hormone in growth hormone deficiency. V. Treatment with growth hormone administered once a week. J Clin Endocrinol Metab 47:686, 1978.

    Article  PubMed  CAS  Google Scholar 

  67. Ferrandez A, Zachmann M, Prader A, et al: Isolated growth hormone deficiency in prepubertal children. Influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. Helv Paediatr Acta 25:566, 1970.

    PubMed  CAS  Google Scholar 

  68. Dean HJ, Kellett JG, Bala RM, et al: The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children. J Clin Endocrinol Metab 55:1167, 1982.

    Article  PubMed  CAS  Google Scholar 

  69. Rosenfeld RG, Kemp SF, Hintz RL: Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab 53:611, 1981.

    Article  PubMed  CAS  Google Scholar 

  70. Preece MA, Tanner JM: Results of intermittent treatment of growth hormone deficiency with human growth hormone. J Clin Endocrinol Metab 45:169, 1977.

    Article  PubMed  CAS  Google Scholar 

  71. Lippe B, Frasier SD, Kaplan SA: Use of growth hormone-gel. Arch Dis Child 54:609, 1979.

    Article  PubMed  CAS  Google Scholar 

  72. MacGillivray MH, Kolotkin M, Munschauer RW: Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone. Pediatr Res 8:103, 1974.

    PubMed  CAS  Google Scholar 

  73. Parker ML: Antibody production in patients receiving human growth hormone and possible therapeutic implications. In: Report of the Fifty-fourth Ross Conference on Pediatric Research, Baltimore, MD, March 1965 ,p. 49.

    Google Scholar 

  74. Kaplan SL, Savage DCL, Suter S, et al: Antibodies to human growth hormone arising in patients treated with human growth hormone: Incidence, characteristics, and effects on growth. In: Advances in Human Growth Hormone Research; A Symposium. U.S. Department of Health, Education and Welfare, Publication No. NIH 74-612, 725, 1973.

    Google Scholar 

  75. Rosenbloom AL, Riley WJ, Silverstein JH, et al: Low dose single weekly injections of growth hormone: Response during first year of therapy of hypopituitarism. Pediatrics 66:272, 1980.

    PubMed  CAS  Google Scholar 

  76. Root AW, Bongiovanni AM, Eberlein WR: Diagnosis and management of growth retardation with special reference to the problem of hypopituitarism. J Pediatr 78:737, 1971.

    Article  PubMed  CAS  Google Scholar 

  77. Lippe BM, Van Herle AJ, LaFranchi SH, et al: Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J Clin Endocrinol Metab 40:612, 1975.

    Article  PubMed  CAS  Google Scholar 

  78. Rubio GR, Mellinger C, Zafar MS, et al: Evaluation of thyroid function during growth hormone therapy. Metabolism 25:15 ,1976.

    Article  PubMed  CAS  Google Scholar 

  79. Cacciari E, Cicognani A, Pirazzoli P, et al: Effect of long-term GH administration on pituitary-thyroid function in idiopathic hypopituitarism. Acta Paediatr Scand 68:405, 1979.

    Article  PubMed  CAS  Google Scholar 

  80. Brown P, Gajdusek DC, Gibbs CJ Jr, et al: Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 313:728, 1985.

    Article  PubMed  CAS  Google Scholar 

  81. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. MMWR 34:359, 1985.

    Google Scholar 

  82. Powell-Jackson J, Weller RO, Kennedy P, et al: Creutzfeld-Jakob disease following human growth hormone administration. Lancet 2:244, 1985.

    Article  PubMed  CAS  Google Scholar 

  83. Koch TK, Berg BO, De Armond SJ, et al: Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 313:731, 1985.

    Article  PubMed  CAS  Google Scholar 

  84. Gibbs CJ Jr, Joy A, Heffner R, et al: Clinical and pathological features and laboratory confirmation of Creutzfeld-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313:734, 1985.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Publishing Corporation

About this chapter

Cite this chapter

Kannan, C.R. (1987). Hypopituitary Dwarfism. In: The Pituitary Gland. Clinical Surveys in Endocrinology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1849-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1849-1_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9032-2

  • Online ISBN: 978-1-4613-1849-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics